Sensitivity and specificity of immunocytochemistry for the detection of tumour cells in the bone marrow of patients with breast cancer;Sensitivitat und spezifitat der immunzytologie fur den tumorzell- nachweis im knochenmark bei patientinnen reit mammakarzinom

Tumor Diagnostik und Therapie

Volumn 20, Issue 2, 1999, Pages 39-44

  Zhong, X Y ^a,b   Kaul, S ^a   Diel, I ^a   Eichler, A ^a   Bastert, C ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Bone marrow; Breast cancer; Detection; Immunocytochemistry; Sensitivity; Specificity; Tumour cell

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; AUTOMATION; BONE MARROW CELL; BREAST CANCER; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOCYTOCHEMISTRY; MEDICAL INSTRUMENTATION; STAINING;

EID: 0032939133     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Costa SD, Kaufmann M, Diel IJ: Klinisch relevante Prognosefaktoren beim Mammarkarzinom. Klin. Labor. 1994; 40: 1153-1166
2. Cohen Y, Zidan J, Meschan D: Bone marrow biopsy in solid cancer. Acta haemat. 1982; 68: 14
3. Renner H, Sauer R, Truog P: Nachweis von Skelertmetastasen mit Hilfe der Knochenmarkbiopsie und des röntgenologischen Skelettstatus im Rahmen der prätherapeutischen Diagnostik beim Bronchialkarzinom. Strahlentherapie. 1975; 150: 18
4. Schlimok G, Funke I, Holzmann B, Gottlinger G, Schmidt G, Hauser H, et al: Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and vivo labeling with anti-17-1A monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1987; 84: 8672-8676
5. Dearnaley DP, Sloane JP, Ormerod MG, Steele K, Coombes RC, Clink HM, et al: Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br. J. Cancer 1981; 44: 85-90
6. Porro G, Menard S, Tagliabue E, Orefice S, Salvadori B, Squicciarini P, et al: Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988; 61: 2407-2411
7. Mansi JL, Berger V, McDonnell, Pople A, Rayter Z, Gazet JC, et al: The fate of bone marrow micrometastases in patients with primary breast cancer. J. Clin. Oncol. 1989; 7: 445-449
8. Delsol G, Gatter KC, Stein H, Erber WN, Pulfod KAE, Zinne K, et al: Human lymphoid cells express epithelial menbrane antigen. Lancet 1984; 2: 1124-1128
9. Pantel K, Braun S, Passlick B, Schlimok G: Minimal Residual Epithelial Cancer: Diagnostic Approaches and Prognostic Relevance. Gustav Fischer Verlag, Stuttgart, New York 1996
10. Thor A, Viglione MJ, Ohuchi N, Simpson J, Steis R, Ceusar J, et al: Comparison of monoclonal antibodies of the detection of occult breast carcinoma metastases in breast bone marrow. Cancer Research and Treatment 1988; 11: 133-145
11. Untch M, Harbeck N, Eiermann W: Micrometastases in bone marrow in patients with breast cancer. British Medical Journal 1988; 296: 290
12. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Amer. J. Clin. Pathol. 1988; 90: 1-6
13. Merkle E. Bähr J, Henke A, Bühner M, Martus P: Immunzytochemischer Nachweis von Tumorzellen im Knochenmark als Prognosefaktor beim Mammakarzinom. Geburth. u. Frauenheilk. 1994; 54: 662-669
14. Kaul S, Zhong XY, Diel I, Bastert G: Tumor cell contamination (TC) in bone marrow of breast cancer patients: Improved sensitivity and quantification of tumor cells using BM2-immunomagnetic beads. Gynecology and Obstetrics 1996; 258: 192
15. Redding WH, Coombes RC, Monaghan P, Clink HM, Imrie SF, Dearnales DP, et al: Detection of micrometastases in patients with primary breast cancer. Lancet 1983; 2: 1271-1274
16. Stahel RA, Mabry M, Skarkin AT, Speak J, Bernal SD: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J. Clin. Oncol. 1985; 3: 455-456
17. Moss TJ, Sanders DG: Detection of neurobiastoma cells in blood. J. Clin. Oncol. 1990; 8: 736-740
18. Moss T, Pantel K, Bik T: Evaluation of grafts for occult tumor cells (editorial). J. Hematother. 1994; 3: 163-164
19. Heyderman E: Immunperoxidase technique in histopathology: applications, methods and controls. Journal of Clinical Pathology 1979; 32: 971-978
20. Diel IJ, Kaufmann M, Solomayer EF, Wallwiener D, Gollan Ch, Goerner R, et al: Prognostische Bedeutung des Tumorzellnachweises im Knochenmark im Vergleich zum Nodalstatus beim primären Mammakarzinom. Geburtsh. u. Frauenheilk. 1997; 57: 333-341
21. Pantel K, Schlimok G, Angstwurm M, Weckermann C, Schmaus W, Gath H, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 1994; 3: 165-173
22. Zotter S, Hageman RC, Losshzer A, Moos WJ, Hilgers J: Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 1988; 11-12: 55-101
23. Bergsagel PL, Victor-Kobrin C, Timblin CR, Trepel J, Kuehl WM: A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J. Immunol. 1992; 148: 590-596
24. Takahashi T, Makiguchi Y, Hinoda Y, Kakiuchi H, Nakagawa N, Imai K, et al: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC 1 from a multiple myeloma patient. The Journal of Immunology 1994; 153: 2102-2109
25. Delsol G, Gatter K, Al Saati T, Stein H, Mason D: Malignant lymphomas expressing an epithelial membrane antigen. Value in the immunohistochemical diagnosis of tumors. Arch. Anat. Cytol. Pathol. 1985; 33: 319
26. Delsol G, Saati TA, Gatter KC, Gerdes J, Schwarting R, Caveriviere P, et al: Coexpression of epithelial membrane antigen (EMA). Ki-1, and interleukin-2 receptor by anaplastic large cell lymphoma. Am J. Pathol. 1988; 130: 59-70
27. Delsol G, Brousset P, Gaspar MH, Rigal Huguet F, Mazerolles C, Barillet Alard C, et al: Current data on large cell anaplastic lymphomas co-expressing EMA, Ki-1 antigens and IL2 receptor. Pathol. Biol. Paris 1989; 37: 1060-1061
28. Delsol G, Brousset P, Schlaifer D: Histogenesis of malignant lymphomas. Rev. Prat. 1993; 43: 1627-1632
29. Zhong XY, Kaul S, Diel I, Bastert G: Tumor cell contamination (TC) in bone marrow of breast cancer patients: sensitive detection by reverse transcriptase-polymerase chain reactions for MUC1, CEA, keratin 19 and GA733-2. Gynecology. and Obstetrics. 1996; 258: 91
30. Schlimok G: Techniken zur Erkennung minimal residueller Erkrankung: Zytologie. Onkologe 1997; 3: 293-297
31. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J. Clin. Oncol. 1992; 10: 1534-1539
32. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave- processed formalin-fixed paraffin sections. J. Pathol. 1992; 168: 357-363